S&P 500   4,284.02 (+0.39%)
DOW   33,806.15 (+0.42%)
QQQ   351.54 (+0.78%)
AAPL   179.19 (+0.77%)
MSFT   323.78 (+0.12%)
META   265.22 (+0.61%)
GOOGL   121.91 (-0.48%)
AMZN   123.93 (+2.23%)
TSLA   231.49 (+3.08%)
NVDA   383.80 (+2.41%)
NIO   7.70 (-0.77%)
BABA   86.47 (+1.40%)
AMD   120.60 (+2.35%)
T   15.98 (-0.75%)
F   13.56 (-0.22%)
MU   65.08 (-2.95%)
CGC   0.70 (-2.59%)
GE   106.83 (+0.71%)
DIS   92.43 (-0.10%)
AMC   4.64 (-1.90%)
PFE   39.13 (+0.62%)
PYPL   64.12 (+0.12%)
NFLX   402.93 (+0.79%)
S&P 500   4,284.02 (+0.39%)
DOW   33,806.15 (+0.42%)
QQQ   351.54 (+0.78%)
AAPL   179.19 (+0.77%)
MSFT   323.78 (+0.12%)
META   265.22 (+0.61%)
GOOGL   121.91 (-0.48%)
AMZN   123.93 (+2.23%)
TSLA   231.49 (+3.08%)
NVDA   383.80 (+2.41%)
NIO   7.70 (-0.77%)
BABA   86.47 (+1.40%)
AMD   120.60 (+2.35%)
T   15.98 (-0.75%)
F   13.56 (-0.22%)
MU   65.08 (-2.95%)
CGC   0.70 (-2.59%)
GE   106.83 (+0.71%)
DIS   92.43 (-0.10%)
AMC   4.64 (-1.90%)
PFE   39.13 (+0.62%)
PYPL   64.12 (+0.12%)
NFLX   402.93 (+0.79%)
S&P 500   4,284.02 (+0.39%)
DOW   33,806.15 (+0.42%)
QQQ   351.54 (+0.78%)
AAPL   179.19 (+0.77%)
MSFT   323.78 (+0.12%)
META   265.22 (+0.61%)
GOOGL   121.91 (-0.48%)
AMZN   123.93 (+2.23%)
TSLA   231.49 (+3.08%)
NVDA   383.80 (+2.41%)
NIO   7.70 (-0.77%)
BABA   86.47 (+1.40%)
AMD   120.60 (+2.35%)
T   15.98 (-0.75%)
F   13.56 (-0.22%)
MU   65.08 (-2.95%)
CGC   0.70 (-2.59%)
GE   106.83 (+0.71%)
DIS   92.43 (-0.10%)
AMC   4.64 (-1.90%)
PFE   39.13 (+0.62%)
PYPL   64.12 (+0.12%)
NFLX   402.93 (+0.79%)
S&P 500   4,284.02 (+0.39%)
DOW   33,806.15 (+0.42%)
QQQ   351.54 (+0.78%)
AAPL   179.19 (+0.77%)
MSFT   323.78 (+0.12%)
META   265.22 (+0.61%)
GOOGL   121.91 (-0.48%)
AMZN   123.93 (+2.23%)
TSLA   231.49 (+3.08%)
NVDA   383.80 (+2.41%)
NIO   7.70 (-0.77%)
BABA   86.47 (+1.40%)
AMD   120.60 (+2.35%)
T   15.98 (-0.75%)
F   13.56 (-0.22%)
MU   65.08 (-2.95%)
CGC   0.70 (-2.59%)
GE   106.83 (+0.71%)
DIS   92.43 (-0.10%)
AMC   4.64 (-1.90%)
PFE   39.13 (+0.62%)
PYPL   64.12 (+0.12%)
NFLX   402.93 (+0.79%)

Privia Health Group (PRVA) Stock Forecast, Price & News

$27.64
+2.36 (+9.34%)
(As of 01:46 PM ET)
Compare
Today's Range
$26.99
$28.30
50-Day Range
$24.01
$29.93
52-Week Range
$20.64
$44.64
Volume
3.46 million shs
Average Volume
1.05 million shs
Market Capitalization
$3.20 billion
P/E Ratio
251.27
Dividend Yield
N/A
Price Target
$39.19

Privia Health Group MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
41.1% Upside
$39.19 Price Target
Short Interest
Bearish
5.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.16mentions of Privia Health Group in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$547.17 M Sold Last Quarter
Proj. Earnings Growth
39.13%
From $0.23 to $0.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

196th out of 981 stocks

Health Services Industry

2nd out of 13 stocks


PRVA stock logo

About Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

WARNING: Do You Invest with these Banks
Take a close look at the investment banks above. Because if you have stocks with any of these brokerages... These new political developments WILL affect you.
Privia Health Group (NASDAQ:PRVA) Stock Price Down 7.5%
Bank Collapse Causes Gold Prices to Soar
Silicon Valley Bank was the second-largest bank in American history to fail, and investors have started piling into the safety and security of gold. But if you're not taking advantage of a little-known way to invest for around $5 today, you're missing out.
RBC Capital Remains a Buy on Privia Health Group (PRVA)
See More Headlines

PRVA Price History

PRVA Company Calendar

Last Earnings
5/04/2023
Today
6/08/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$39.19
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+42.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
0.12%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.53 per share

Miscellaneous

Free Float
49,041,000
Market Cap
$3.18 billion
Optionable
Not Optionable
Beta
0.76

Key Executives

  • Mr. Matthew Shawn MorrisMr. Matthew Shawn Morris (Age 59)
    CEO & Director
    Comp: $1.66M
  • Mr. Parth MehrotraMr. Parth Mehrotra (Age 44)
    Pres & COO
    Comp: $1.37M
  • Mr. David Mountcastle CPAMr. David Mountcastle CPA (Age 52)
    MBA, Exec. VP, CFO & Principal Accounting Officer
    Comp: $882.07k
  • Mr. Thomas BartrumMr. Thomas Bartrum (Age 56)
    Exec. VP & Gen. Counsel
    Comp: $608.79k
  • Mr. Chris Voigt
    Exec. VP & Chief Technology Officer
  • Mr. Robert P. Borchert
    Sr. VP of Investor Relations & Corp. Communications
  • Ms. Dana Fields CPA
    Sr. VP of Internal Audit & Chief Compliance Officer
  • Ms. Jenny Harding
    Sr. VP of People Operations
  • Mr. Jay Stevens
    Sr. VP & Chief Growth Officer
  • Dr. S. Mark Cone FACOG (Age 60)
    M.D., Pres of Privia Medical Group - Gulf Coast Texas













PRVA Stock - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price forecast for 2023?

13 Wall Street research analysts have issued 12 month target prices for Privia Health Group's shares. Their PRVA share price forecasts range from $28.00 to $51.00. On average, they predict the company's share price to reach $39.19 in the next twelve months. This suggests a possible upside of 42.6% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 on January 1st, 2023. Since then, PRVA shares have increased by 21.0% and is now trading at $27.48.
View the best growth stocks for 2023 here
.

Are investors shorting Privia Health Group?

Privia Health Group saw a increase in short interest in May. As of May 15th, there was short interest totaling 5,740,000 shares, an increase of 189.9% from the April 30th total of 1,980,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is presently 4.9 days. Approximately 5.4% of the company's stock are sold short.
View Privia Health Group's Short Interest
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings data on Thursday, May, 4th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.03. The company earned $386.28 million during the quarter, compared to analysts' expectations of $378.17 million. Privia Health Group had a trailing twelve-month return on equity of 3.20% and a net margin of 1.14%.

What guidance has Privia Health Group issued on next quarter's earnings?

Privia Health Group updated its FY 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.55 billion-$1.65 billion, compared to the consensus revenue estimate of $2.79 billion.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is Privia Health Group's stock symbol?

Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.99%), Bank of New York Mellon Corp (3.09%), Principal Financial Group Inc. (1.99%), Riverbridge Partners LLC (1.96%), FMR LLC (1.47%) and Franklin Resources Inc. (1.09%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Privia Health Group's stock price today?

One share of PRVA stock can currently be purchased for approximately $27.48.

How much money does Privia Health Group make?

Privia Health Group (NASDAQ:PRVA) has a market capitalization of $3.18 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does Privia Health Group have?

The company employs 964 workers across the globe.

How can I contact Privia Health Group?

The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.

This page (NASDAQ:PRVA) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -